<table frame="void" id="AC4EC6D7-3B43-4209-8A04-17F34B6E9C24" xmlns="urn:hl7-org:v3" xmlns:voc="http://www.hl7.org/v3/voc" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><caption>Table 1. Select Mean (±S.D.) Metformin Pharmacokinetic Parameters Following Single or Multiple Oral Doses of Metformin</caption>
<thead>
<tr><td align="left" valign="top"><content stylecode="bold">Select Groups:</content></td><td align="center" valign="bottom"></td><td align="center" valign="bottom"></td><td align="center" valign="bottom"><content stylecode="bold">Renal</content></td></tr>
<tr><td align="left" valign="top"><content stylecode="bold">Metformin HCl</content></td><td align="center" valign="bottom"><content stylecode="bold">C</content><content stylecode="bold"><sub>max</sub></content><content stylecode="bold"><sup>b</sup></content></td><td align="center" valign="bottom"><content stylecode="bold">T</content><content stylecode="bold"><sub>max</sub></content><content stylecode="bold"><sup>c</sup></content></td><td align="center" valign="bottom"><content stylecode="bold">Clearance</content></td></tr>
<tr><td align="left" valign="top"><content stylecode="bold">Dose</content><content stylecode="bold"><sup>a</sup></content><content stylecode="bold"> (number of subjects</content></td><td align="center" valign="bottom"><content stylecode="bold">(µg/mL)</content></td><td align="left" valign="bottom"><content stylecode="bold">(hrs)</content></td><td align="center" valign="bottom"><content stylecode="bold">(mL/min)</content></td></tr>
</thead>
<tfoot>
<tr><td align="left" colspan="4" valign="top"><sup>a</sup> All doses given fasting except the first 18 doses of the multiple dose studies;</td></tr>
<tr><td align="left" colspan="4" valign="top"><sup>b</sup> Peak plasma concentration;</td></tr>
<tr><td align="left" colspan="4" valign="top"><sup>c</sup> Time to peak plasma concentration;</td></tr>
<tr><td align="left" colspan="4" valign="top"><sup>d</sup> Combined results (average means) of five studies: mean age 32 years (range 23-59 yrs).</td></tr>
<tr><td align="left" colspan="4" valign="top"><sup>e</sup> Kinetic study done following dose 19, given fasting.</td></tr>
<tr><td align="left" colspan="4" valign="top"><sup>f</sup> Elderly subjects, mean age 71 years (range 65-81 years).</td></tr>
<tr><td align="left" colspan="4" valign="top"><sup>g</sup> CL<sub>cr </sub>= creatinine clearance normalized to body surface area of 1.73 m<sup>2</sup>.</td></tr>
</tfoot>
<tbody>
<tr><td align="left" valign="top"><content stylecode="bold">Healthy, nondiabetic adults:</content></td><td align="center" valign="top"></td><td align="center" valign="top"></td><td align="center" valign="top"></td></tr>
<tr><td align="left" valign="top">500 mg single dose (24)</td><td align="center" valign="top">1.03 (±0.33)</td><td align="center" valign="top">2.75 (±0.81)</td><td align="center" valign="top">600 (±132)</td></tr>
<tr><td align="left" valign="top">850 mg single dose (74)<sup>d</sup></td><td align="center" valign="top">1.60 (±0.38)</td><td align="center" valign="top">2.64 (±0.82)</td><td align="center" valign="top">552 (±139)</td></tr>
<tr><td align="left" valign="top">850 mg three times daily for</td><td align="center" valign="top"></td><td align="center" valign="top"></td><td align="center" valign="top"></td></tr>
<tr><td align="left" valign="top">19 doses<sup>e</sup> (9)</td><td align="center" valign="top">2.01 (±0.42)</td><td align="center" valign="top">1.79 (±0.94)</td><td align="center" valign="top">642 (±173)</td></tr>
<tr><td align="left" valign="top"><content stylecode="bold">Adults with type 2 diabetes:</content></td><td align="center" valign="top"></td><td align="center" valign="top"></td><td align="center" valign="top"></td></tr>
<tr><td align="left" valign="top">500 mg single dose (23)</td><td align="center" valign="top">1.48 (±0.5)</td><td align="center" valign="top">3.32 (±1.08)</td><td align="center" valign="top">491 (±138)</td></tr>
<tr><td align="left" valign="top">850 mg three times daily for</td><td align="center" valign="top"></td><td align="center" valign="top"></td><td align="center" valign="top"></td></tr>
<tr><td align="left" valign="top">19 doses<sup>e</sup> (9)</td><td align="center" valign="top">1.90 (±0.62)</td><td align="center" valign="top">2.01 (±1.22)</td><td align="center" valign="top">550(±160)</td></tr>
<tr><td align="left" valign="top"><content stylecode="bold">Elderly</content><content stylecode="bold"><sup>f</sup></content><content stylecode="bold">, healthy nondiabetic adults</content></td><td align="center" valign="top"></td><td align="center" valign="top"></td><td align="center" valign="top"></td></tr>
<tr><td align="left" valign="top">850 mg single dose (12)</td><td align="center" valign="top">2.45 (±0.70)</td><td align="center" valign="top">2.71 (±1.05)</td><td align="center" valign="top">412 (±98)</td></tr>
<tr><td align="left" valign="top"><content stylecode="bold">Renal-impared adults:</content></td><td align="center" valign="top"></td><td align="center" valign="top"></td><td align="center" valign="top"></td></tr>
<tr><td align="left" valign="top">850 mg single dose</td><td align="center" valign="top"></td><td align="center" valign="top"></td><td align="center" valign="top"></td></tr>
<tr><td align="left" valign="top"><content stylecode="bold">Mild </content>(CL<sub>cr</sub><sup>g</sup> 61-90 mL/min) (5)</td><td align="center" valign="top">1.86 (±0.52)</td><td align="center" valign="top">3.20 (±0.45)</td><td align="center" valign="top">384 (±122)</td></tr>
<tr><td align="left" valign="top"><content stylecode="bold">Moderate</content> (CL<sub>cr</sub> 31-60 mL/min) (4)</td><td align="center" valign="top">4.12 (±1.83)</td><td align="center" valign="top">3.75 (±0.50)</td><td align="center" valign="top">108 (±57)</td></tr>
<tr><td align="left" valign="top"><content stylecode="bold">Severe </content>(CL<sub>cr</sub> 10-30 mL/min) (6)</td><td align="center" valign="top">3.93 (±0.92)</td><td align="center" valign="top">4.01 (±1.10)</td><td align="center" valign="top">130 (±90)</td></tr>
</tbody>
</table>